Silva, Adriana F.
Torres, Marcelo D. T.
Silva, Leandro S.
Alves, Flavio L.
Miranda, Antonio
Oliveira, Vani X. Jr
de la Fuente-Nunez, Cesar
Pinheiro, Ana Acacia S.
Funding for this research was provided by:
Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/08527-3, 2014/12938-6)
National Institute of General Medical Sciences (R35GM138201)
Defense Threat Reduction Agency (HDTRA11810041)
Article History
Received: 20 October 2023
Accepted: 3 January 2024
First Online: 26 February 2024
Competing interests
: Cesar de la Fuente-Nunez provides consulting services to Invaio Sciences and is a member of the Scientific Advisory Boards of Nowture S.L. and Phare Bio. The de la Fuente Lab has received research funding or in-kind donations from United Therapeutics, Strata Manufacturing PJSC, and Procter & Gamble, none of which were used in support of this work. Other authors do not have a competing interest.